Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
使用抗CK2合成肽治疗可改善新冠肺炎合并肺炎患者的临床疗效。一项随机对照临床试验
期刊:ACS Pharmacology and Translational Science
影响因子:3.7
doi:10.1021/acsptsci.0c00175
Cruz, Leticia R; Baladrón, Idania; Rittoles, Aliusha; Díaz, Pablo A; Valenzuela, Carmen; Santana, Raúl; Vázquez, Maria M; García, Ariadna; Chacón, Deyli; Thompson, Delvin; Perera, Gustavo; González, Ariel; Reyes, Rafael; Torres, Loida; Pérez, Jesus; Valido, Yania; Rodriguez, Ralysmay; Vázquez-Bloomquist, Dania M; Rosales, Mauro; Ramón, Ailyn C; Pérez, George V; Guillén, Gerardo; Muzio, Verena; Perera, Yasser; Perea, Silvio E